Eukles Asset Management’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.09M | Sell |
4,479
-155
| -3% | -$65.2K | 0.86% | 39 |
|
|
2026
Q1 | $1.75M | Sell |
4,634
-1,422
| -23% | -$609K | 0.78% | 42 |
|
|
2025
Q4 | $2.59M | Buy |
6,056
+25
| +0.4% | +$10.9K | 1.01% | 34 |
|
|
2025
Q3 | $2.7M | Buy |
6,031
+24
| +0.4% | +$10.9K | 1.05% | 31 |
|
|
2025
Q2 | $2.93M | Sell |
6,007
-12
| -0.2% | -$6.84K | 1.2% | 29 |
|
|
2025
Q1 | $3.7M | Sell |
6,019
-172
| -3% | -$97.8K | 1.63% | 17 |
|
|
2024
Q4 | $3.28M | Sell |
6,191
-366
| -6% | -$206K | 1.4% | 25 |
|
|
2024
Q3 | $3.94M | Sell |
6,557
-128
| -2% | -$72.6K | 1.58% | 19 |
|
|
2024
Q2 | $3.63M | Sell |
6,685
-61
| -0.9% | -$34.9K | 1.57% | 19 |
|
|
2024
Q1 | $4.33M | Buy |
6,746
+100
| +2% | +$60.8K | 1.88% | 15 |
|
|
2023
Q4 | $3.89M | Sell |
6,646
-50
| -0.7% | -$28K | 1.84% | 16 |
|
|
2023
Q3 | $3.48M | Buy |
6,696
+45
| +0.7% | +$23.4K | 1.84% | 16 |
|
|
2023
Q2 | $3.6M | Sell |
6,651
-23
| -0.3% | -$12.6K | 1.84% | 17 |
|
|
2023
Q1 | $3.59M | Sell |
6,674
-85
| -1% | -$43.3K | 1.95% | 14 |
|
|
2022
Q4 | $3.45M | Sell |
6,759
-296
| -4% | -$144K | 2.01% | 14 |
|
|
2022
Q3 | $3.08M | Sell |
7,055
-128
| -2% | -$61.6K | 2.02% | 13 |
|
|
2022
Q2 | $3.37M | Sell |
7,183
-14
| -0.2% | -$6.83K | 2.13% | 13 |
|
|
2022
Q1 | $3.65M | Sell |
7,197
-163
| -2% | -$78.2K | 1.98% | 13 |
|
|
2021
Q4 | $3.89M | Buy |
7,360
+73
| +1% | +$35K | 1.88% | 17 |
|
|
2021
Q3 | $3.39M | Buy |
7,287
+377
| +5% | +$178K | 1.85% | 16 |
|
|
2021
Q2 | $3.28M | Buy |
6,910
+242
| +4% | +$116K | 1.82% | 16 |
|
|
2021
Q1 | $3.07M | Buy |
6,668
+372
| +6% | +$182K | 1.98% | 16 |
|
|
2020
Q4 | $3.35M | Buy |
6,296
+48
| +0.8% | +$23.6K | 2.32% | 12 |
|
|
2020
Q3 | $3M | Buy |
6,248
+40
| +0.6% | +$19.6K | 2.34% | 12 |
|
|
2020
Q2 | $2.8M | Buy |
6,208
+204
| +3% | +$91.1K | 2.38% | 11 |
|
|
2020
Q1 | $2.6M | Sell |
6,004
-287
| -5% | -$128K | 2.71% | 7 |
|
|
2019
Q4 | $2.76M | Sell |
6,291
-63
| -1% | -$26.5K | 2.25% | 12 |
|
|
2019
Q3 | $2.65M | Sell |
6,354
-33
| -0.5% | -$13.5K | 2.3% | 10 |
|
|
2019
Q2 | $2.31M | Sell |
6,387
-31
| -0.5% | -$10.4K | 2% | 14 |
|
|
2019
Q1 | $2.05M | Sell |
6,418
-16
| -0.2% | -$4.91K | 1.87% | 15 |
|
|
2018
Q4 | $1.82M | Buy |
+6,434
| New | +$1.94M | 1.9% | 15 |
|
Other funds holding CHE
EIP
Eukles Asset Management's CHE Position: Q2 2026 in Review
Eukles Asset Management reduced its Chemed (CHE) stake by 3.3% in Q2 2026, selling an estimated $65.2K and leaving 4,479 shares worth $2.09M. The position accounts for 0.86% of the portfolio, ranked #39.
Eukles Asset Management first reported a position in CHE in Q4 2018 and has held it in 31 quarters since. The position peaked at $4.33M in Q1 2024. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.
- Eukles Asset Management held 4,479 shares of Chemed worth $2.09M as of Q2 2026.
- Eukles Asset Management sold 155 Chemed shares in Q2 2026, an estimated $65.2K.
- Chemed made up 0.86% of Eukles Asset Management's portfolio in Q2 2026, its #39 holding.
- Eukles Asset Management first reported a position in Chemed in Q4 2018 and has held it in 31 quarters since.
- Eukles Asset Management's Chemed position peaked at $4.33M in Q1 2024.
- 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.
Based on Eukles Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.